X4 Pharmaceuticals Inc (XFOR) NPV
Sell:$0.46Buy:$0.47
$0.01
(1.33%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$0.46
Buy:$0.47
Change:$0.01
(1.33%)
$0.01
(1.33%)Prices delayed by at least 15 minutes
Sell:$0.46
Buy:$0.47
Change:$0.01
(1.33%)
$0.01
(1.33%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 January 2025 | Paula S. RaganPresident/CEO | Sell Tax related | 76,473 | $0.45 | $34,718.74 | 1,087,386 |
| 24 January 2025 | Mary DiBiaseCOO | Sell Tax related | 22,258 | $0.45 | $10,094.00 | 490,980 |
| 24 January 2025 | Mark BaldryChief Level Officer | Sell Tax related | 29,159 | $0.45 | $13,241.10 | 94,123 |
| 24 January 2025 | Christophe Arbet-EngelsOther Level A | Sell Tax related | 11,624 | $0.45 | $5,284.27 | 14,207 |
| 24 January 2025 | Adam S MostafaCFO | Sell Option/Award related | 74,773 | $0.45 | $33,946.94 | 0 |
| 15 November 2024 | Paula S. RaganPresident/CEO | Sell Regular sell transaction (market) | 31,897 | $0.39 | $12,583.37 | 993,919 |
| 15 November 2024 | Mark BaldryChief Level Officer | Buy Regular purchase transaction | 13,404 | $0.34 | $4,597.57 | 129,173 |
| 15 October 2024 | Paula S. RaganPresident/CEO | Sell Regular sell transaction (market) | 31,897 | $0.56 | $17,926.11 | 1,025,816 |
| 7 October 2024 | Paula S. RaganPresident/CEO | Sell Option/Award related | 239,436 | $0.55 | $131,522.19 | 1,057,713 |
| 7 October 2024 | Mary DiBiaseCOO | Sell Option/Award related | 67,695 | $0.57 | $38,328.91 | 452,060 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 7 October 2024 | Paula S. RaganPresident/CEO | Sell Option/Award related | 239,436 | $0.55 | $131,522.19 | 1,057,713 |
| 7 October 2024 | Adam S MostafaCFO | Sell Option/Award related | 230,645 | $0.55 | $126,900.88 | 0 |
| 11 March 2024 | Adam S MostafaCFO | Sell Regular sell transaction (market) | 52,500 | $0.88 | $46,347.00 | 0 |
| 11 March 2024 | Paula S. RaganPresident/CEO | Sell Regular sell transaction (market) | 49,678 | $0.88 | $43,855.74 | 765,068 |
| 7 October 2024 | Arthur TaverasChief Level Officer | Sell Tax related | 76,920 | $0.56 | $43,305.96 | 388,026 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.